Overview

Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study

Status:
Completed
Trial end date:
2020-05-30
Target enrollment:
Participant gender:
Summary
To study the effectiveness and safety profiles of photodynamic therapy (PDT) for the treatment of human retinoblastoma.
Phase:
N/A
Details
Lead Sponsor:
Sun Yat-sen University